Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stereotaxis, Inc. Common Stock (NY:STXS)

2.920 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 273
Open 2.920
Bid (Size) 2.900 (5)
Ask (Size) 3.000 (9)
Prev. Close 2.920
Today's Range 2.920 - 2.920
52wk Range 1.540 - 3.590
Shares Outstanding 90,653,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
New Robotic System Promises Faster, Safer Care For Arrhythmia Patients
Stereotaxis (AMEX: STXS) announces first procedures with Genesis Robotic Magnetic Navigation System for minimally invasive endovascular interventions. 
Via Benzinga
Stereotaxis Inc (NYSEARCA:STXS) Q2 2025 Earnings: Revenue Surpasses Forecasts, Losses Narrower Than Expected
Stereotaxis Inc (NYSE:STXS) Q2 2025 earnings beat revenue estimates with $8.8M, narrowing losses to -$0.05 EPS. Stock rose 1.83% post-announcement. 
Via Chartmill
Topics Earnings

Performance

YTD
+27.5%
+27.5%
1 Month
-6.1%
-6.1%
3 Month
+28.6%
+28.6%
6 Month
+44.6%
+44.6%
1 Year
+49.7%
+49.7%

More News

Read More
Earnings Scheduled For August 7, 2025
Via Benzinga
Earnings Scheduled For May 12, 2025
Via Benzinga
What's Going On With Stereotaxis Shares Wednesday?
Via Benzinga
Earnings Scheduled For March 3, 2025
Via Benzinga
Stereotaxis Earnings Preview
Via Benzinga
Earnings Scheduled For November 11, 2024
Via Benzinga
STXS Stock Earnings: Stereotaxis Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Hyliion Holdings And 3 Other Penny Stocks Insiders Are Buying
Via Benzinga
STXS Stock Earnings: Stereotaxis Meets EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Recap: Stereotaxis Q4 Earnings
Via Benzinga
Earnings Preview For Stereotaxis
Via Benzinga
Recap: Stereotaxis Q3 Earnings
Via Benzinga
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
Via InvestorPlace
7 Penny Stocks That Could 5X by the End of 2024
Via InvestorPlace
Low-Priced, High-Potential: 7 Cheap Stocks Under $10 to Try Your Luck With
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For March 4, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Insiders Buying Eyenovia And 3 Other Stocks Under $2
Via Benzinga
Topics Stocks
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Stereotaxis And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
Topics Stocks
Stereotaxis Clocks 28% Revenue Growth In Q2 On Continued Demand For Robotic Technology
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga

Frequently Asked Questions

Is Stereotaxis, Inc. Common Stock publicly traded?
Yes, Stereotaxis, Inc. Common Stock is publicly traded.
What exchange does Stereotaxis, Inc. Common Stock trade on?
Stereotaxis, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Stereotaxis, Inc. Common Stock?
The ticker symbol for Stereotaxis, Inc. Common Stock is STXS on the New York Stock Exchange
What is the current price of Stereotaxis, Inc. Common Stock?
The current price of Stereotaxis, Inc. Common Stock is 2.920
When was Stereotaxis, Inc. Common Stock last traded?
The last trade of Stereotaxis, Inc. Common Stock was at 10/30/25 08:00 PM ET
What is the market capitalization of Stereotaxis, Inc. Common Stock?
The market capitalization of Stereotaxis, Inc. Common Stock is 264.71M
How many shares of Stereotaxis, Inc. Common Stock are outstanding?
Stereotaxis, Inc. Common Stock has 265M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.